IBIO
iBio, Inc. Common Stock
NASDAQ: IBIO · HEALTHCARE · BIOTECHNOLOGY
$1.59
-5.92% today
Updated 2026-05-01
Market cap
$57.47M
P/E ratio
—
P/S ratio
191.56x
EPS (TTM)
$-1.00
Dividend yield
—
52W range
$1 – $4
Volume
1.0M
iBio, Inc. Common Stock (IBIO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-8,491.00%
ROE
-70.20%
ROA
-37.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | $896273.00 | $-1.67M | 50.27% | -185.77% | -185.88% |
| 2008 | $987058.00 | $-1.87M | 50.85% | -189.05% | -189.35% |
| 2009 | $1.18M | $-1.91M | 33.29% | -163.64% | -162.02% |
| 2010 | $27000.00 | $-6.08M | — | -16,988.89% | -22,511.11% |
| 2011 | $520080.00 | $-12.14M | 100.00% | -1,856.25% | -2,334.64% |
| 2012 | $1.28M | $-5.68M | 100.00% | -730.38% | -444.48% |
| 2013 | $1.01M | $-6.20M | 100.00% | -662.07% | -615.49% |
| 2014 | $205000.00 | $-3.67M | 100.00% | -1,873.17% | -1,788.29% |
| 2015 | $1.85M | $-6.63M | 100.00% | -360.13% | -357.91% |
| 2016 | $948000.00 | $-9.76M | 100.00% | -1,043.57% | -1,029.96% |
| 2017 | $394000.00 | $-14.53M | 100.00% | -3,622.84% | -3,688.32% |
| 2018 | $444000.00 | $-16.11M | 100.00% | -3,204.28% | -3,627.25% |
| 2019 | $2.02M | $-17.59M | 100.00% | -782.36% | -871.80% |
| 2020 | $1.64M | $-16.44M | 57.08% | -854.88% | -1,003.60% |
| 2021 | $2.37M | $-23.21M | 38.34% | -1,312.15% | -978.79% |
| 2022 | $1.88M | $-50.39M | -101.22% | -1,576.27% | -2,674.68% |
| 2023 | $50000.00 | $-29.31M | 100.00% | -58,622.00% | -58,622.00% |
| 2024 | $225000.00 | $-24.91M | 100.00% | -7,392.89% | -11,069.78% |
| 2025 | $400000.00 | $-18.38M | 100.00% | -4,650.50% | -4,594.25% |